ADVERTISEMENT
One of President Donald Trump’s signature 2024 campaign promises was to do something to help lower the cost of prescription drugs.
Prescription drug prices have recorded their largest annual decline in more than six decades, providing the Trump administration with a major talking point as its Most-Favored-Nation drug-pricing initiative takes effect.
The latest federal inflation data show prescription drug prices continuing to fall, including a 0.8% decline in July alone.
The administration attributes much of the decline to Trump’s Most-Favored-Nation policy, which is designed to bring prices paid by Americans closer to the lowest prices available in other developed countries.
Trump launched the initiative through a May 2025 executive order aimed at ending the longstanding disparity between what Americans pay for prescription medicines and prices charged for the same drugs overseas.
ADVERTISEMENT
ADVERTISEMENT